Why is "Hemophilia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-04 20:39:28
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Haemophilia, or hemophilia, is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding for a longer time after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or an altered level of consciousness.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
With factor IX deficiency, saying I have ‘hemophilia’ isn’t specific enough - Hemophilia News Today
-
Clinical Scenarios in Hospitalized Patients With Hemophilia - Cureus
-
Improving Health-Related Quality of Life for Children With Hemophilia - Hematology Advisor
-
Pediatric Video Tutorial: Hemophilia Types & Treatments Take 2 - HMP Global Learning Network
-
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
-
What Hemophilia and Sickle Cell Disease Reveal About the Future of Gene Therapy Access - Pharmacy Times
-
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - NEJM
-
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
-
INOVIO to show mouse hemophilia treatment data on April 22 - Stock Titan
-
Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy - McLaren Health
-
Marstacimab Prophylaxis for Hemophilia With Inhibitors: BASIS Trial Adds Evidence - Docwire News
-
Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
-
Protein marker may detect early joint damage in hemophilia A - Hemophilia News Today
-
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
-
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
-
Struggling with loneliness in the early days of my sons’ hemophilia - Hemophilia News Today
-
After my son’s diagnosis, hearing he’d ‘live a long life’ what just what I needed - Hemophilia News Today
-
Global survey finds many women with hemophilia face diagnostic gaps - Hemophilia News Today
-
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
-
Therapeutic advances in hemophilia: from molecular innovation to patient-centered global care - frontiersin.org
-
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
-
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
-
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
-
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
-
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
-
Growing up before treatments for hemophilia were safe, part 1 - Hemophilia News Today
-
Hemophilia gene therapies are struggling on the market, even as innovation soars - Pharma Voice
-
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
-
Exploring gene editing as a potential therapeutic strategy for hemophilia - frontiersin.org
-
An MD-PhD Student Had Hemophilia - Right as Rain by UW Medicine
-
Utah Center for Bleeding & Clotting Disorders at University of Utah Health Administers New Gene Therapy for Hemophilia B - School of Medicine | University of Utah
-
Transformative approaches in hemophilia management: from traditional therapies to prenatal stem cell treatment - frontiersin.org
-
AI-Driven Applications Changing the Management of Hemophilia - Hematology Advisor
-
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
-
On the Ground in Uzbekistan Hemophilia Care Challenges and Insights - Global Biotechnology Company
-
Pfizer says patient dies after receiving hemophilia drug in trial - Reuters
-
Gene therapy for hemophilia - Hemophilia News Today
-
Advances in hemophilia gene therapy bring hope for pediatric patients - News-Medical
-
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - NEJM
-
Hemophilia B Gene Therapy Continues to Reduce Bleeding - Medscape
-
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
-
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
-
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
-
Pfizer Advances Beam’s Gene Editor After Pulling Hemophilia Gene Therapy - BioSpace
-
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
-
Managing Breakthrough Bleeding in Hemophilia: Strategies and Considerations - Pharmacy Times
-
COVID-19-Associated Acquired Hemophilia A With an Exceptionally High Inhibitor Titer: A Case of Remission and Overwhelming Sepsis - Cureus
-
VCU expands access to care for adults with bleeding disorders - VCU Health
-
Bio Major’s Research Points the Way to New Hemophilia Treatment - Davidson College
-
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
-
Silent Avascular Necrosis of the Femoral Head in Severe Hemophilia A: A Case Report - Cureus
-
European Medicines Agency Issues Positive Opinion for Concizumab Label Update in Hemophilia - Docwire News
-
AAV Gene Therapy in Severe Hemophilia B - NEJM
-
Evolving treatment paradigms in hemophilia: A written recap - managedhealthcareexecutive.com
-
More Hemophilia Treatment Choices Despite Gene Therapy Setbacks - managedhealthcareexecutive.com
-
Understanding Hemophilia A and B: Essential Insights for Pharmacists - Pharmacy Times
-
An Initial Diagnosis of Acquired Hemophilia A in an Elderly Male With a Neck Hematoma - Cureus
-
Author Correction: Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs - Nature
-
Monitoring and Managing Adverse Events in Hemophilia Prophylaxis - Pharmacy Times
-
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - managedhealthcareexecutive.com
-
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
-
CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix - Fierce Pharma
-
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - frontiersin.org
-
Recognizing and Managing Breakthrough Bleeding in Hemophilia - Pharmacy Times
-
Recurrent Subdural Hematoma Revealing Undiagnosed Mild Hemophilia A and Factor XIII Deficiency in an Elderly Patient - Cureus
-
Roctavian Gene Therapy Controls Bleeding for Five Years in Severe Hemophilia A - managedhealthcareexecutive.com
-
A Case Report on Emergency Medicine: Suspected Acquired Hemophilia A in an Older Adult Male - Cureus
-
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report - frontiersin.org
-
How Gene Therapy Is Transforming Hemophilia B Treatment - Docwire News
-
Sanofi backs 2 more films about rare blood disorders - Fierce Pharma
-
Advances in hemophilia treatment | Windyga | Acta Haematologica Polonica - Via Medica Journals
-
Expanding Alhemo to hemophilia without inhibitors recommended - Hemophilia News Today
-
The Surprising Rare Disease That Tore Through the Royal Family - Prevention
-
Byron family shares son’s journey with Severe Hemophilia A - MyStateline
-
Assessing stigma in a predominantly male hemophilia population: a Chinese cross-sectional study - frontiersin.org
-
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - frontiersin.org
-
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - Medical Professionals Reference
-
Discovery could improve treatment for people with hemophilia A - Medical Xpress
-
Veterinarian aims to bring hemophilia treatment to pet dogs - News - VIN
-
Pfizer’s Hympavzi Cuts Bleeding by 93% in Hemophilia A and B Patients with Inhibitors, Phase 3 Trial Finds - managedhealthcareexecutive.com
-
A New, Viable Approach in Hemophilia: Inhibition of Activated Protein C - Docwire News
-
Development of a short form of the Swedish version of the Hemophilia Activities List - Nature
-
These Weird Symptoms Could Suggest You Have a Serious Blood Condition - Prevention
-
Safe Outpatient Dental Management of a Pediatric Patient With Mild Hemophilia A: A Case Report - Cureus
-
New FVIII Mutation Offers Insights for Future Hemophilia A Treatments - managedhealthcareexecutive.com
-
Novo Nordisk to present phase 3 trials across hemophilia portfolio, reinforcing commitment to research in rare blood disorders, at ISTH 2025 - PR Newswire
-
'Freedom From the Need': A Pharmacist's Journey From Constant Hemophilia B Treatment to Gene Therapy - Pharmacy Times
-
Pfizer's hemophilia drug Hympavzi notches phase 3 win as pharma eyes label expansion - Fierce Pharma
-
Six biotech companies leading the charge in hemophilia treatment - labiotech.eu
-
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
-
Surat Hemophilia Care Centre provides free treatment in India - The News Mill
-
Marion Dugdale, a ‘True Academic Physician,’ Pioneered Hemophilia Care in Memphis - UTHSC News
-
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
-
It’s time to change how we classify hemophilia severity - Hemophilia News Today
-
Hemophilia Isn’t Just for Him - Lehigh Valley Health Network
-
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - NEJM
-
Acquired Hemophilia A Presenting as a Spontaneous Soft Tissue Hematoma in an Elderly Male - Cureus
-
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapy - frontiersin.org
-
UK: population with hemophilia/bleeding disorders 2023 - Statista
-
Hemophilia Gene Therapy Is Shown to Last 13 Years for Blood Disorder: Study - Bloomberg.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.